These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38178729)

  • 1. Different effects of CO
    Qi Y; Mo K; Wang A; He Y
    J Obstet Gynaecol Res; 2024 Apr; 50(4):671-681. PubMed ID: 38178729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cost-effectiveness analysis of vaginal carbon dioxide laser therapy compared with standard medical therapies for genitourinary syndrome of menopause-associated dyspareunia.
    Wallace SL; St Martin B; Lee K; Sokol ER
    Am J Obstet Gynecol; 2020 Dec; 223(6):890.e1-890.e12. PubMed ID: 32562659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Double-Blind Randomized Sham-Controlled Trial to Evaluate the Efficacy of Fractional Carbon Dioxide Laser Therapy on Genitourinary Syndrome of Menopause.
    Cruff J; Khandwala S
    J Sex Med; 2021 Apr; 18(4):761-769. PubMed ID: 33757774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Fractional CO
    Li J; Li H; Zhou Y; Xie M; Miao Y; Wang L; Zhao Y; Ying T; Hu Y; Chen Y; Chen Y; Sun X; Wang J
    Lasers Surg Med; 2021 Jul; 53(5):647-653. PubMed ID: 33211334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Short-term efficacy of vaginal CO
    Kozma B; Póka R; Sipos A; Ács N; Takács P
    Orv Hetil; 2019 Oct; 160(41):1617-1622. PubMed ID: 31587579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized clinical trial comparing vaginal laser therapy to vaginal estrogen therapy in women with genitourinary syndrome of menopause: The VeLVET Trial.
    Paraiso MFR; Ferrando CA; Sokol ER; Rardin CR; Matthews CA; Karram MM; Iglesia CB
    Menopause; 2020 Jan; 27(1):50-56. PubMed ID: 31574047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of a vaginal CO
    Mejia-Gomez J; Bouteaud J; Philippopoulos E; Wolfman W; Brezden-Masley C
    Climacteric; 2022 Jun; 25(3):228-234. PubMed ID: 34694948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CO2-Laser therapy and Genitourinary Syndrome of Menopause: A Systematic Review and Meta-Analysis.
    Filippini M; Porcari I; Ruffolo AF; Casiraghi A; Farinelli M; Uccella S; Franchi M; Candiani M; Salvatore S
    J Sex Med; 2022 Mar; 19(3):452-470. PubMed ID: 35101378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fractional and Microablative CO
    Caceres Nogueira MC; Homem de Mello Bianchi-Ferraro AM; Leonor Pereira Campos M; Dias Oliveira C; Gracio Ferreira Sartori M; Di Bella ZIKJ; Logullo AF; ; Speck NMG
    Photobiomodul Photomed Laser Surg; 2024 Jun; 42(6):414-421. PubMed ID: 38888192
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of CO
    Latul YP; Vodegel EV; Kastelein AW; Alkemade L; Ras L; Hilty MP; Favaron E; Ince Y; Ince C; Jeffery S; Guler Z; Roovers JWR
    Neurourol Urodyn; 2023 Aug; 42(6):1381-1389. PubMed ID: 37334848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fractional CO2 laser therapy for genitourinary syndrome of menopause for breast cancer survivors.
    Quick AM; Zvinovski F; Hudson C; Hundley A; Evans C; Suresh A; Stephens JA; Arthur E; Ramaswamy B; Reinbolt RE; Noonan AM; VanDeusen JB; Wesolowski R; Stover DG; Williams NO; Sardesai SD; Smith KL; Faubion SS; Loprinzi CL; Lustberg MB
    Support Care Cancer; 2020 Aug; 28(8):3669-3677. PubMed ID: 31811486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations of vaginal microbiota with the onset, severity, and type of symptoms of genitourinary syndrome of menopause in women.
    Zeng Q; Shu H; Pan H; Zhang Y; Fan L; Huang Y; Ling L
    Front Cell Infect Microbiol; 2024; 14():1402389. PubMed ID: 39380726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of fractional CO
    Tovar-Huamani J; Mercado-Olivares F; Grandez-Urbina JA; Pichardo-Rodriguez R; Tovar-Huamani M; García-Perdomo H
    Lasers Surg Med; 2019 Aug; 51(6):509-515. PubMed ID: 30779363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaginal laser therapy for GSM/VVA: where we stand now - a review by the EUGA Working Group on Laser.
    Salvatore S; Ruffolo AF; Phillips C; Athanasiou S; Cardozo L; Serati M;
    Climacteric; 2023 Aug; 26(4):336-352. PubMed ID: 37395104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CO
    Salvatore S; Pitsouni E; Grigoriadis T; Zacharakis D; Pantaleo G; Candiani M; Athanasiou S
    Climacteric; 2021 Apr; 24(2):187-193. PubMed ID: 33089713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of promestriene with vaginal fractional CO2 laser and radiofrequency treatments of genitourinary syndrome of menopause.
    Seganfredo IB; Bianchi C; Tacla M; Chedraui P; Haddad JM; Simoes R; Baracat EC; Soares JM
    Maturitas; 2024 Aug; 186():108008. PubMed ID: 38714422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Severity of Genitourinary Syndrome of Menopause Symptoms After Carbon Dioxide Laser vs Vaginal Estrogen Therapy: A Systematic Review and Meta-analysis.
    Jang YC; Leung CY; Huang HL
    JAMA Netw Open; 2022 Sep; 5(9):e2232563. PubMed ID: 36129710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rationale and design for fractional microablative CO
    Flint R; Cardozo L; Grigoriadis T; Rantell A; Pitsouni E; Athanasiou S
    Climacteric; 2019 Jun; 22(3):307-311. PubMed ID: 30676818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of a novel fractional CO2 laser for the treatment of genitourinary syndrome of menopause: 1-year outcomes.
    Sokol ER; Karram MM
    Menopause; 2017 Jul; 24(7):810-814. PubMed ID: 28169913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and long-term efficacy of fractional CO
    Behnia-Willison F; Sarraf S; Miller J; Mohamadi B; Care AS; Lam A; Willison N; Behnia L; Salvatore S
    Eur J Obstet Gynecol Reprod Biol; 2017 Jun; 213():39-44. PubMed ID: 28419911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.